Fletcher MM, et al
Cagrilintide is a long-acting amylin receptor agonist
Preclinical studies showed no adverse effects across several organ systems including liver, spleen, lung, kidney, brain, thymus, prostate, and ovaries in studies up to 6 weeks
It targets the largest part of the shoulder muscle and is a good option for addressing general rotator cuff inflammation or impingement syndrome, where the pain is felt on the top or side of the shoulder
Insulinthe first peptide made in a labhas been saving the lives of people with diabetes for more than a century
In some preclinical studies, BPC-157 has been shown to speed up recovery from tendon ruptures and ligament injuries, suggesting it may have applications in sports medicine and physical therapy